Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Clinical Case Reports|March 26, 2021
High-grade B-cell lymphoma developed during the treatment of chronic myeloid leukemia with bosutinibTeruhito Takakuwa, Ryota Sakai, Shiro Koh, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 24, 2003
[Primary malignant lymphoma arising from the nipple and areolar area of the breast]Takahiko Nakane, Takahisa Yamane, Hisako Shibata, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 11, 2019
[Successful treatment with rituximab in acute disseminated encephalomyelitis with whole spinal cord involvement following HLA haploidentical transplantation]Yosuke Makuuchi, Mitsutaka Nishimoto, Keiichi Yamamoto, et al.
Acta Haematologica|April 4, 2013
Dasatinib maintenance therapy after allogeneic hematopoietic stem cell transplantation for an isolated central nervous system blast crisis in chronic myelogenous leukemiaMitsutaka Nishimoto, Hirohisa Nakamae, Ki-Ryang Koh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 15, 2007
[Improved outcome in brain abscess during induction in acute myelocytic leukemia]Takahiko Nakane, Takahisa Yamane, Hirohisa Nakamae, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 7, 2019
[Refractory ascites caused by lymphatic flow disorder after stem cell transplantation for acute myeloid leukemia]Teruhito Takakuwa, Takahiro Okuno, Mitsutaka Nishimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 2020
[High-dose polyclonal intravenous immunoglobulin therapy for refractory viral infections including viremia after allogeneic hematopoietic cell transplantation]Kentaro Ido, Takahiko Nakane, Hiroshi Okamura, et al.
Cancer Science|August 4, 2017
Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T-cell lymphomaDai Maruyama, Hirokazu Nagai, Yoshinobu Maeda, et al.
Leukemia & Lymphoma|January 4, 2012
Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinibYoshiki Hayashi, Hirohisa Nakamae, Takako Katayama, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 15, 2015
[Cold autoimmune hemolytic anemia complicated with relapsed myelodysplastic syndrome after allogeneic hematopoietic cell transplantation]Hiroshi Okamura, Takahiko Nakane, Keizo Fujino, et al.
Pageof 9